COCH
Envoy Medical·NASDAQ
--
--(--)
--
--(--)
6.19 / 10
Outperform
Analyst consensus is a single Strong Buy, giving a bullish sentiment, while fund‑flow rating is good (6.89/10). Medium‑size inflows are positive, but overall and large‑cap trends are negative, highlighting mixed capital dynamics.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Edward WooStrong Buy
Date2025-05-27
InstitutionAscendiant Capital
Times predicted2
Historical Win Rate50.0%
What is the analyst consensus for COCH?
- COCH holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.19/10 (Outperform).
